Patient Hopes Dashed as FDA Fails to Tackle Hidden Clinical Trial Results


September 14, 2020

As seen on TranspariMED blog – Posted Sept. 14, 2020 – Original Article

Sept. 14, 2020 | The US Food and Drug Administration has dashed patient hopes that it will take rapid and decisive action to force pharmaceutical companies and universities to make the results of their clinical trials public as required by law.

Thomas Wicks, chief strategy officer for TrialScope, says the emphasis is on encouraging rather than enforcing compliance.

Continued on TranspariMED blog